CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,825.00
-17.00 (-0.92%)
Feb 14, 2025, 9:00 AM KST
-22.67%
Market Cap 270.84B
Revenue (ttm) 94.36B
Net Income (ttm) 2.89B
Shares Out 138.89M
EPS (ttm) 10.72
PE Ratio 181.82
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 279,149
Average Volume 328,602
Open 1,842.00
Previous Close 1,842.00
Day's Range 1,815.00 - 1,848.00
52-Week Range 1,590.00 - 2,525.00
Beta 0.64
RSI 62.78
Earnings Date Mar 21, 2025

About CMG Pharmaceutical

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutic... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 273
Stock Exchange KOSDAQ
Ticker Symbol 058820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.